Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.
Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: izumi y. Basic Clin Pharmacol Toxicol. 2022 Dec;131(6):525-535. doi: 10.1111/bcpt.13799. Epub 2022 Oct 7. Basic Clin Pharmacol Toxicol. 2022. PMID: 36169161 Free article.
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Okada N, Izumi Y, Nakamoto A, Chuma M, Goda M, Yagi K, Aizawa F, Hamano H, Zamami Y, Azuma M, Ishizawa K. Okada N, et al. Among authors: izumi y. Clin Ther. 2021 Nov;43(11):1910-1920.e3. doi: 10.1016/j.clinthera.2021.09.007. Epub 2021 Oct 9. Clin Ther. 2021. PMID: 34642081
Concomitant Use of Multiple Nephrotoxins including Renal Hypoperfusion Medications Causes Vancomycin-Associated Nephrotoxicity: Combined Retrospective Analyses of Two Real-World Databases.
Bando T, Chuma M, Hamano H, Niimura T, Okada N, Kondo M, Izumi Y, Ishida S, Yoshioka T, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Izawa-Ishizaka Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K. Bando T, et al. Among authors: izumi y. Acta Med Okayama. 2023 Dec;77(6):595-605. doi: 10.18926/AMO/66151. Acta Med Okayama. 2023. PMID: 38145933 Free article.
Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan.
Ohneda K, Suzuki Y, Hamanaka Y, Tadaka S, Shimada M, Hasegawa-Minato J, Takahashi M, Fuse N, Nagami F, Kawame H, Kobayashi T, Yamaguchi-Kabata Y, Kinoshita K, Nakamura T, Ogishima S, Kumada K, Kudo H, Kuriyama SI, Izumi Y, Shimizu R, Tochigi M, Motonari T, Tokunaga H, Kikuchi A, Masamune A, Aoki Y, Ishioka C, Ishida T, Yamamoto M. Ohneda K, et al. Among authors: izumi y. J Hum Genet. 2025 Jan 17. doi: 10.1038/s10038-024-01314-w. Online ahead of print. J Hum Genet. 2025. PMID: 39825003
Association Between Sodium- and Potassium-Related Urinary Markers and the Prevalence of Atrial Fibrillation.
Tokioka S, Nakaya N, Hatanaka R, Nakaya K, Kogure M, Chiba I, Takase M, Nochioka K, Susukita K, Metoki H, Nakamura T, Ishikuro M, Obara T, Hamanaka Y, Orui M, Kobayashi T, Uruno A, Kodama EN, Nagaie S, Ogishima S, Izumi Y, Fuse N, Kuriyama S, Yasuda S, Hozawa A. Tokioka S, et al. Among authors: izumi y. Circ J. 2025 Jan 11. doi: 10.1253/circj.CJ-24-0780. Online ahead of print. Circ J. 2025. PMID: 39805599 Free article.
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.
Mahalingam D, Owonikoko TK, Delpassand E, Mulcahy MF, Kalyan A, Ulahannan S, Cheung K, Izumi Y, Johansen M, Madden T, Shimoyama S, Subach RA, Suzuki T, Wages DS, Wheeler C, Richardson DL. Mahalingam D, et al. Among authors: izumi y. Cancer. 2025 Jan 1;131(1):e35680. doi: 10.1002/cncr.35680. Cancer. 2025. PMID: 39748726 Free PMC article. Clinical Trial.
2,153 results